4 Results for "

CDK4-IN-7

" in MedChemExpress (MCE) Product Catalog:
Products (4)

4 Results for "CDK4-IN-7" in MCE Product Catalog:

Cat. No.: HY-184444
CAS No.: 3113087-01-4
Target:  

CDK

Research Areas:  

Cancer

CDK4-IN-7 is a CDK4 inhibitor with an IC50 of 26 nM. CDK4-IN-7 shows selectivity for CDK1, with an IC50 of 4.2262 μM. CDK4-IN-7 can be used in cancer research .
loading...
    loading...
2
2 Cited Publications
Cat. No.: HY-13914
CAS No.: 1223498-69-8
Purity:  98.09%
Synonyms: BAY 1000394
Target:  

CDK

Research Areas:  

Cancer

Roniciclib is an orally bioavailable pan-cyclin dependent kinase (CDK) inhibitor, with IC50s of 5-25 nM for CDK1, CDK2, CDK3, CDK4, CDK7 and CDK9.
loading...
    loading...
Cat. No.: HY-146276
CAS No.: 2580938-58-3
Target:  

HDAC CDK Apoptosis

Research Areas:  

Cancer

CDK/HDAC-IN-2 is a potent HDAC/CDK dual inhibitor with IC50 of 6.4, 0.25, 45, >1000, 8.63, 0.30, >1000 nM for HDAC1, HDAC2, HDAC3, HDAC6,8, CDK1, CDK2, CDK4,6,7, respectively. CDK/HDAC-IN-2 shows excellent antiproliferative activities. CDK/HDAC-IN-2 induces apoptosis and cell cycle arrest at G2/M phase. CDK/HDAC-IN-2 shows potent antitumor efficacy .
loading...
    loading...
Cat. No.: HY-170651
Target:  

CDK HDAC Apoptosis

Research Areas:  

Cancer

CDK4/6/HDAC-IN-1 (Compound N14) is a dual-targeting inhibitor of CDK4/6 and HDAC (IC50: CDK4 = 7.23 nM, CDK6 = 13.20 nM, HDAC1 = 55.66 nM, HDAC6 = 48.38 nM). CDK4/6/HDAC-IN-1 induces cell Apoptosis and G0/G1 phase arrest through HDAC-p21-CDK signaling pathway. CDK4/6/HDAC-IN-1 inhibits hepatocellular carcinoma .
loading...
    loading...